AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

VHL Vitasora Health Limited

Healthcare · Health Information Services · website
$0.01
52wk 0.01 – 0.04
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Vitasora Health Limited

Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$23.40M
P/E (trailing)
P/E (forward)
-10.00
EPS (trailing)
-0.01
Dividend yield
Payout ratio
0.0%
Beta
-0.39
EV / EBITDA
-1.51
Price / Book
1.11
ROE
-106.3%
Operating margin
-180.0%
Net margin
-231.4%
Total cash
$3.10M
Total debt
$26,509
Current ratio
2.95
Debt / Equity
0.00
Free cash flow
$-6.06M
Avg volume
1.69M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$3.09M
  • Gross profit$3.06M
  • Operating income-$10.72M
  • Net income-$10.11M
  • Diluted EPS-0.01
  • Free cash flow-$9.17M
  • Net debt-$336.82K
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9